
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Ytterbium-176
Therapeutic Area : Oncology
Study Phase : Undisclosed
Sponsor : Point Biopharma
Deal Size : Undisclosed
Deal Type : Agreement
Details : With this agreement with Kinectrics, POINT to access large quantities of highly enriched Yb-176, creating the world’s first, stable North American supply of n.c.a. Lu-177, thereby establishing POINT as a dependable provider of high-quality radiopharmac...
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Undisclosed
October 29, 2021
Lead Product(s) : Ytterbium-176
Therapeutic Area : Oncology
Highest Development Status : Undisclosed
Sponsor : Point Biopharma
Deal Size : Undisclosed
Deal Type : Agreement
